Clinical Trial Update: Tislelizumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update exploring tislelizumab with concurrent chemoradiotherapy for locally advanced cervical cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Cervical Neoplasms

Drugs mentioned

• Tislelizumab (tislelizumab)

Snippet

Sponsor: Yong Zhang,MD | Conditions: Uterine Cervical Neoplasms | Phase 2 | Status: UNKNOWN